Current Month 2013
Article Features
  A Genome-Forward Approach to Tackling Drug Resistant Cancers
Analyzing the Cost-Effectiveness of California Breast Cancer Screening Program
Depletion of ĎTraitorí Immune Cells Slows Cancer Growth in Mice
Diabetes Increases the Risk of Developing and Dying From Breast and Colon Cancer
Different Stories Play Different Roles in Patient Decision Making
First Randomized Trial of Targeted Cancer Medicine in All Tumor Types
Functional Disability High Among Newly-Diagnosed Older Breast Cancer Patients
Gene Expression-Based Biomarker Predicts Long-Term Risk of Breast Cancer Recurrence
Immune Cells Open Window To Breast Cancer Risk
Mental Fog with Tamoxifen is Real; Study Finds Possible Antidote
New Breast Cancer Imaging Technique Could Cut Down on False Positives
New Models of Drug-Resistant Breast Cancer Hint at Better Treatments
New Protein Knowledge Offers Hope for Better Cancer Treatment
Radiotherapy in Girls and the Risk of Breast Cancer Later in Life
Scientists ID Protein That Regulates Cellular Trafficking, Potential for Anti-Cancer Therapy
Study Helps Deconstruct Estrogenís Role in Memory
Study Helps Deconstruct Estrogenís Role in Memory
Study Provides Big Picture View of How Cancer Cells Are Supported by Normal Cells In and Near Tumors
Task Force Issues Final Recommendations on Medications for Risk Reduction of Primary Breast Cancer in Women
Unfounded Fear of Recurrence Prompts Young Breast Cancer Patients to Remove Healthy Breasts
Versatile MicroRNAs Choke Off Cancer Blood Supply, Suppress Metastasis


Unfounded Fear of Recurrence Prompts Young Breast Cancer Patients to Remove Healthy Breasts

Despite evidence that contralateral prophylactic mastectomy (CPM) does not improve survival rates, an increasing number of young women with breast cancer elect to remove their healthy breast to avoid recurrence and improve survival.

Researchers surveyed 123 women aged 40 or younger without known bilateral breast cancer who reported having bilateral mastectomy. The purpose of the survey was to better understand how women approach the decision to have CPM. The survey included questions about the women's health history, reason for choosing CPM, and knowledge and perceptions about breast cancer. Most of the women (n = 97) had stage I or stage II breast cancer and 60 percent of tumors were estrogen receptor-positive.

The findings were published in the journal Annals of Internal Medicine.

Almost all (98 percent) of the women surveyed indicated that desires to decrease their risk for contralateral breast cancer (CBC) prompted their decision to remove the healthy breast. Although 94 percent of the women surveyed said they chose bilateral mastectomy to increase survival, only 18 percent reported thinking that CPM improved survival rates. Almost all of the women surveyed overestimated the actual risk of CBC.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon